Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 6 of 6)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
23-Nov-09 Reuters Investment Profile N/A VaxGen Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
8-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for VaxGen Incorporated 43 $65 View Abstract
27-Oct-09 Life Science Analytics Life Science Analytics VaxGen Inc-Company Report 35 $150 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala VAXGEN INC (VXGN=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala VAXGEN INC (VXGN=US) 2-weeks forecast 1 $10 View Abstract
4-Apr-08 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for VXGN 13 $25 View Abstract

Independent Reports (Showing 1 to 6 of 6)

Release
Date Contributor Author Title Pages Price More Info
23-Nov-09 Reuters Investment Profile N/A VaxGen Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
8-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for VaxGen Incorporated 43 $65 View Abstract
27-Oct-09 Life Science Analytics Life Science Analytics VaxGen Inc-Company Report 35 $150 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala VAXGEN INC (VXGN=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala VAXGEN INC (VXGN=US) 2-weeks forecast 1 $10 View Abstract
4-Apr-08 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for VXGN 13 $25 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.